Project Grant 2441592

Award Date 1/1/25
Completion Date 12/31/29
Dollars Obligated $117K
Federal Grant Program
47.049
Assistance Type
Project Grant
Place of Performance
Fountain Hill, PA 18015, USA
Similar Awards
This federal Project Grant award of $200,000, made by the National Science Foundation (NSF) under the Engineering program (CFDA 47.041), aims to integrate non-viral CRISPR gene activation and deep learning to understand the impact of cell manipulation and gene activation on stem cell differentiation. The key objectives are to: (1) decouple the effects of cell transfection and CRISPR-mediated activation (CRISPRa) on mesenchymal stromal cell (MSC) therapeutic capacity, and (2) bridge the gap...
This $509,070 Project Grant award from the National Science Foundation's Division of Molecular and Cellular Biosciences (CFDA 47.074 Biological Sciences) supports research at Purdue University to explore the working mechanism of CRISPR-Cas12 endonucleases and analogues. The primary goals are to investigate the regulatory mechanisms of natural CRISPR inhibitor proteins, and to dissect the structural dynamics of newly identified Cas12 analogues found in mobile genetic elements and viruses. This...
The National Institute of Biomedical Imaging and Bioengineering awarded a $276,000 Project Grant (R21EB036298) to the Scripps Research Institute in La Jolla, CA under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) federal grant program. The grant supports research to develop advanced and safer CRISPR-Cas9 genome editing tools using directed evolution methods. The goal is to engineer Cas9 proteins that are compatible with fully chemically...
This National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) project grant award for $1,000,000 aims to characterize the molecular mechanisms by which the bridge helix (BH) region of the CRISPR-Cas9 and CRISPR-Cas12a enzymes contributes to DNA cleavage fidelity and mismatch tolerance. The research will leverage computational modeling and simulations to identify how BH allostery regulates the nuclease activity of these genome editing enzymes, with the goal of engineering...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports research to improve the efficiency of CRISPR gene editing in human pluripotent stem cells. The goal is to develop a novel carbon nanotube array technology that can efficiently transfer nucleic acids and proteins into these cells to enhance CRISPR-based gene editing and homology-directed recombination. The $275,045 award to Advanced...
This five-year $385,645 Project Grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) will fund research investigating RNA-guided nucleases encoded by transposons across the three domains of life. The grantee, Columbia University, will examine an ancestral family of transposon-encoded enzymes that use guide RNAs to target and cut matching DNA sequences. These enzymes are directly related to CRISPR-Cas9 and CRISPR-Cas12 genome editing tools. The project aims to...
This Project Grant award of $150,620.00 from the National Science Foundation's (NSF) Mathematical and Physical Sciences (CFDA 47.049) program supports research conducted by the Colorado School of Mines to develop new polymer-mediated delivery methods for genome-editing proteins. The key goals are to: 1) reveal how polymer properties influence binding, loading, and size of polymer-protein complexes for different genome-editing proteins; 2) tailor polymer composition to accommodate diverse...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $100,000 will support research to develop next-generation clustered regularly interspaced short palindromic repeat (CRISPR) systems for curing inherited diseases. Specifically, the awardee, the University of California, Berkeley, will work to circumvent in vivo delivery challenges with CRISPR-Cas9 by developing miniature RNA-guided genome editors smaller than Cas9 that can be...
This $322,020 Project Grant award from the National Science Foundation's (NSF) Division of Integrative Organismal Systems will support collaborative research at the University of California, Davis (UC Davis) to develop improved methods for CRISPR/Cas9-based gene editing in maize. The key objectives are to generate maize lines expressing high levels of Cas9 nuclease and to engineer and optimize viral vectors to efficiently deliver guide RNAs for both somatic and heritable gene editing. This...
The National Science Foundation (NSF) awarded a $800,000 Project Grant under its Biological Sciences program (CFDA 47.074) to The Regents of the University of California, doing business as University of California, Berkeley. The grant funding will support collaborative research to discover and characterize compact CRISPR gene editing systems that can be encoded in plant viruses. This will enable more efficient and widespread deployment of genome editing capabilities across a variety of crop...

This $117,074 federal Project Grant award was provided by the National Science Foundation (NSF) Division of Materials Research under the Mathematical and Physical Sciences (CFDA 47.049) program. The grant supports a research project led by Lehigh University focused on leveraging biomaterials to enhance the safety and efficacy of CRISPR gene editing tools. The key objectives are to: 1) determine how peptide-based nanoparticle formulation and properties impact CRISPR uptake, activity, and functionality; 2) decouple the effects of material charge and porosity on the temporal action of CRISPR nanoparticles; and 3) establish the impact of cell-material interactions on CRISPR cellular uptake and editing efficiency. This multi-level research approach aims to provide new insights for designing safer and more effective CRISPR delivery systems to advance gene editing technology for clinical and research applications. The project period runs from January 1, 2025 to December 31, 2029 and does not include any sub-awards.

Generated 4/8/25, 4:40 AM